NUR 641E WK DQ1 Discussion
According to Kiko et al. (2017), cardiomyopathy is a cardiovascular system disease that makes it difficult for the heart to pump blood throughout the body. People with one of the various types of cardiomyopathy often suffer from heart failure. The main types of this disease are restrictive, dilated, and hypertrophic cardiomyopathy. NUR 641E WK DQ1 Discussion
Dilated cardiomyopathy affects the pumping ability of the main chamber of the heart. The left ventricle is seen to become enlarged and unable to pump blood from the heart (Mayala, 2019). This form of cardiomyopathy is more prominent in middle-age people, often resulting from a heart attack or coronary heart disease. On the other hand, hypertrophic cardiomyopathy involves a thickening of the heart muscle, especially the left ventricle. The thickened muscles make it difficult for the heart to work effectively. Unlike dilated cardiomyopathy, this form may develop at any age but is more severe in childhood. The disease is majorly congenital and has been linked to some genetic mutations.
Restrictive cardiomyopathy is where the heart muscles lose their elasticity and become rigid. The heart, therefore, has difficulty dilating and filling with blood during heartbeats. This is the least prevalent form of cardiomyopathy, and while it may occur at any age, it is more common in older people. A disease may cause it within the body that affects the heart, such as hemochromatosis, or it may occur for no reason ((Mayala, 2019). NUR 641E WK DQ1 Discussion
Treatment for cardiomyopathy may involve medication. However, in severe cases could call for a heart transplant. The mode of treatment is dependent not only on the type of cardiomyopathy but also on the severity of the disease. In the early stages, cardiomyopathy may have no symptoms. However, as the condition advances, symptoms will appear including; coughing while lying down, breathlessness even when at rest, fluid build-up in the abdomen causing bloating, swelling of the legs, feet and ankles, fatigue, dizziness and fainting, rapid heartbeat, and chest pressure or discomfort (Mayala, 2019).
Kiko, T., Yoshihisa, A., Kimishima, Y., Sato, Y., Watanabe, S., Kanno, Y., … & Oikawa, M. (2017). Urinary N-terminal Fragment of Titin Distinguishes Muscular Dystrophy From Other Types of Cardiomyopathy. Circulation, 136(suppl_1), A12153-A12153.
Mayala, H. A. (2019). The role of Cardiac Magnetic Resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review. Malawi Medical Journal, 31(3), 243-247.NUR 641E WK DQ1 Discussion